Virtual Screening of Cyanobacterial Metabolites as Inhibitors
of SARS-CoV-2 Host Cell Entry, Viral Replication,
and Host Immunity Modulation Infective Mechanisms
Viktor Aloysius A. Fellizar1,2, Aaron Cyrus A. Concepcion1,2,
Emmanuel Louise A. Furaque1,2, Angela Maxine G. Fabian1,2,
Von Novi O. de Leon1,3, Delfin Yñigo Pilapil IV1,3, Mark Tristan J. Quimque1,5,6,
Kin Israel R. Notarte1,4, and Allan Patrick G. Macabeo1*
1Laboratory for Organic Reactivity, Discovery, and Synthesis (LORDS),
Research Center for the Natural and Applied Sciences, University of Santo Tomas,
España Blvd., Manila 1015 Philippines
2Science, Technology, Engineering, and Mathematics (STEM), Senior High School,
University of Santo Tomas, España Blvd., Manila 1015 Philippines
3Department of Biological Sciences, College of Science, University of Santo Tomas,
España Blvd., Manila 1015 Philippines
4Faculty of Medicine and Surgery, University of Santo Tomas,
España Blvd., Manila 1015 Philippines
5Department of Chemistry, College of Science and Mathematics
Mindanao State University–Iligan Institute of Technology
Tibanga, Iligan City 9200 Philippines
6The Graduate School, University of Santo Tomas, España Blvd., Manila 1015 Philippines
*Corresponding author: This email address is being protected from spambots. You need JavaScript enabled to view it.
[Download]
Fellizar VA et al. 2022. Virtual Screening of Cyanobacterial Metabolites as
Inhibitors of SARS-CoV-2 Host Cell Entry, Viral Replication, and Host Immunity
Modulation Infective Mechanisms. Philipp J Sci 151(6B): 2385–2416.
https://doi.org/10.56899/151.6B.07
